It used a different product called PCO-02, with 1 mg BPC-157 tabletsnot Barrier or InfiniWells finished products
Careful monitoring and adherence to maximum dosage recommendations are essential to prevent systemic toxicity
This upstream mechanism means Tesamorelin works through the bodys natural GH/IGF-1 axis rather than bypassing it, which is why it produces measurable increases in both growth hormone and IGF-1 levels, in contrast to AOD-9604s more targeted, IGF-1-sparing profile
Product Specifications Key Research Focus Areas AOD 9604 has gained significant traction in the scientific community due to its unique mechanisms of action observed in vivo and in vitro: Targeted Lipolysis Studies: Investigated for its ability to stimulate fat-burning mechanisms without impacting blood glucose levels or insulin sensitivity
This avoids any osmotic disruption from bacteriostatic water
It is not a medicine, supplement, food, cosmetic, medical device, diagnostic product or treatment product